4-Aminopyridine Sustained Release

Known as: 4 Aminopyridine Sustained Release, Sustained Release, 4-Aminopyridine, Fampridine SR

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2017

2017

The effect of Fampridine-SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS.

Sarah Anne Morrow, Heather Rosehart, Andrew M. Johnson
Multiple sclerosis and related disorders
2017

BACKGROUND Cognitive fatigue (CF) is a common complaint in persons with MS (PwMS). Fampridine-SR improves ambulation, fatigue and… (More)

Is this relevant?

1997

1997

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis.

Steven R. Schwid, Mary D Petrie, Michael P. Mcdermott, David S Tierney, David H. Mason, Andrew D. Goodman
Neurology
1997

OBJECTIVE To evaluate the efficacy of 4-aminopyridine sustained release (4AP SR) (fampridine, EL-970) using quantitative measures… (More)

Is this relevant?